U.S. markets closed

OrganiGram Holdings Inc. (OGI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9402+0.0231 (+2.52%)
At close: 04:00PM EDT
0.9255 -0.01 (-1.56%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close0.9171
Bid0.9250 x 800
Ask0.9460 x 1000
Day's Range0.9211 - 0.9500
52 Week Range0.9100 - 3.1300
Avg. Volume4,531,614
Market Cap294.931M
Beta (5Y Monthly)1.19
PE Ratio (TTM)N/A
EPS (TTM)-0.0910
Earnings DateJul 11, 2022 - Jul 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.87
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for OGI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Organigram Holdings Inc.
    Analyst Report: Aurora Cannabis Inc.Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • Business Wire

    Proposed Settlement Reached in 2016 Class Action

    TORONTO, June 24, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), and its subsidiary Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis in Canada, has reached a proposed settlement ("Settlement") in a previously disclosed class action related to medical cannabis that was voluntarily recalled in December 2016 and January 2017 ("Class Action"). The Supreme Court of Nova Scotia (the "Court") approved notice of Settlement will be sent to class

  • Investopedia

    Top Marijuana Stocks on the Nasdaq for June 2022

    These are the marijuana stocks on the Nasdaq with the best value, fastest growth, and best performance for June 2022.

  • Investopedia

    Top Marijuana Stocks for June 2022

    These are the marijuana stocks with the best value, fastest growth, and best performance for June 2022.